KALYDECO*
- Ivacaftor- Kalydeco- @- (Jan- 2012)- Metabolic disorder
Compositions:
Ivacaftor- mg,
List of Related Indications:
Ivacaftor- mg,
- Treatment of rare form of cystic fibrosis(CF) in patients ages 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator(CFTR) gene
Strength | Rate | Packing Style |
---|---|---|
mg | 0.00 | unit |